Skip to main content

Oxagen, University of Warwick Win 2M Grant for Genome-Wide GPCR Research

NEW YORK, March 6 - UK-based Oxagen and The University of Warwick have jointly won a grant for £2 million, or $3 million, to chart genome-wide functional variation in the genes for G-protein coupled receptors.

The three-year grant from the LINK Applied Genomics Programme will bring together yeast-based systems developed at Warwick for high-throughput GPCR-function analysis with Oxagen's experience in large-scale genetic analysis.

The grant is the largest made by the Management Committee for the LINK Programme in Applied Genomics since it was created in July 2000. The grant itself is co-funded by the UK Department of Trade and Industry, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council.

 

Click here for more information.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.